SARS-Cov-2

In 2020, there was an increase in pulmonary embolism-related mortality not limited only to patients with confirmed SARS-CoV-2 infection, according to a research letter published in the Journal of the American College of Cardiology.

Adults who received heart transplants from SARS-CoV-2-positive donors experienced similar 30-day and 1-year outcomes compared with recipients of SARS-CoV-2-negative hearts, according to a registry analysis.

I was a college student at University of Texas in the mid-90s, when the book The Hot Zone by Richard Preston was released.

Patients who received biologic treatment for asthma did not experience higher SARS-CoV-2 infection rates than the general population, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Older adults with dementia are at greater risk for SARS-CoV-2 infection and death, highlighting the need for close monitoring of these patients, researchers reported in the Journal for Alzheimer’s Disease.

As with society in general, COVID-19 has created varied challenges for the infectious disease pharmacist community. However, as identified, the challenge of pivoting work and a constantly shifting landscape of available therapies were universal.

Infectious disease pharmacists provide a broad spectrum of services for patients, but like other health care professionals, they have faced changes since the emergence of COVID-19, and their role has expanded.

Fatigue and headache were the most common symptoms reported by people an average of 4 months after COVID-19 infection, according to research in Brain, Behavior, & Immunity.

Many patients experienced significant hair loss following COVID-19 infection, according to a case series published in the Journal of Drugs and Dermatology.

Compared with women who did not have SARS-CoV-2, those who were infected during the third trimester of pregnancy had a higher risk for preterm birth, data in PLoS One showed.